New Zealand

Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy…

Prior +2.3%HICP +3.3% vs +3.9% y/y expectedPrior +2.5% This is the first indication that higher energy prices are…

Kelowna lawyer found to have misappropriated $54K in estate funds Published 12:54 pm Wednesday, March 25, 2026 A…

Apple released visionOS 26.4 this week, bringing VR foveated streaming and a key improvement to spatial audio in…

The first crewed mission of NASA’s Artemis moon program may take off in a matter of days, with…

Amazon MGM Studios’ “Project Hail Mary” is off to a phenomenal start, both critically and commercially, pulling in…

BTS / Courtesy of BigHit Music Samsung Electronics Co. said Friday it has partnered with global superstars BTS…

Rachel Platten took the world by storm when she released “Fight Song” in 2015, and even after 11…

Did you know that the Australian Sand Sculpting Championships existed? I didn’t until just a few minutes ago,…

Four years ago, the people of Reddit gathered in r/Fauxmoi to share their celebrity and pop culture-related predictions…

In the ADlong Phase 3b study, nearly all EBGLYSS-treated patients achieved meaningful skin improvement (EASI-75) for up to…

Phase 3b data presented at AAD Annual Meeting show Lilly’s Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity